Rigel Pharmaceuticals Stock (NASDAQ: RIGL) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 1.421M |
Day Range | - - - |
52 Wk Range | 0.712 - 1.960 |
Market Cap | $198.207M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 38 |
Short Interest | 2.92% |
Days to Cover | 5.46 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Rigel Pharmaceuticals (NASDAQ: RIGL) through any online brokerage.
Other companies in Rigel Pharmaceuticals’s space includes: Zura Bio (NASDAQ:ZURA), Outlook Therapeutics (NASDAQ:OTLK), Innate Pharma (NASDAQ:IPHA), Galectin Therapeutics (NASDAQ:GALT) and Adverum Biotechnologies (NASDAQ:ADVM).
The latest price target for Rigel Pharmaceuticals (NASDAQ: RIGL) was reported by Citigroup on Thursday, March 7, 2024. The analyst firm set a price target for 4.00 expecting RIGL to rise to within 12 months (a possible 253.98% upside). 9 analyst firms have reported ratings in the last year.
The stock price for Rigel Pharmaceuticals (NASDAQ: RIGL) is $1.13 last updated April 24, 2024 at 6:51 PM EDT.
There are no upcoming dividends for Rigel Pharmaceuticals.
Rigel Pharmaceuticals’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Rigel Pharmaceuticals.
Rigel Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.